Finepoint Capital LP 13F holdings
Finepoint Capital LP reported 5 positions with a total reported value of $461.0M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-13. Top holdings by reported value: QXO QXO INC (67.9%), RXO RXO INC (32.0%), ANNA ALEANNA INC (<0.1%), MNY MONEYHERO LIMITED (<0.1%), CLDI CALIDI BIOTHERAPEUTICS INC (<0.1%). Against 2026-03-31 it opened 0 new positions and exited 0. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Finepoint Capital LP files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| QXO QXO INC | 18,113,850 | $313.0M | 67.9% |
| RXO RXO INC | 5,355,445 | $147.8M | 32.0% |
| ANNA ALEANNA INC | 517,717 | $227.4K | <0.1% |
| MNY MONEYHERO LIMITED | 895,000 | $37.0K | <0.1% |
| CLDI CALIDI BIOTHERAPEUTICS INC | 1,042 | $177 | <0.1% |
New positions this quarter
No new positions.
Sold out
No positions were sold out.
Biggest increases and decreases
Increases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| QXO QXO INC | 13,858,415 | 18,113,850 | +30.7% | $313.0M |
Decreases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| RXO RXO INC | 10,073,618 | 5,355,445 | -46.8% | $147.8M |

